Oral Semaglutide is a compounded medication that contains Semaglutide, a synthetic version of the naturally occurring hormone GLP-1 (glucagon-like peptide-1)
While not all GLP1 agents show the same magnitude of benefit, the trend is clear GLP1 MASLD MASH treatment holds real potential for altering the trajectory of liver disease in high-risk populations
While the findings are observational and most participants in the study were older white men with diabetes, which could limit how broadly the results apply to other groups, experts not involved in the study said they provide a helpful big-picture view
doi: 10.1016/j.parkreldis.2018.08.005 57
Both are top-tier molecules for health, offering a range of benefits to help you function at your best
Understanding how to initiate, titrate, and monitor these agents can help optimize patient outcomes across multiple domains